ResearcherTianjin Medical University Cancer Institute and HospitalNo recent work listed
Mingxiao Lang
Matched on ORCID iD 0000-0001-7216-060X; OpenAlex author ID A5083600523. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper
Papers 7
- Retraction notice to "HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma" [Cancer Lett. 453 (2019… Co-author DOI 10.1016/j.canlet.2023.216059↗
- SOX8 Affects Tumoral SPARC Expression by Regulating EZH2 to Attenuate Effectiveness of albumin-bound paclitaxel in PDAC. Co-author DOI 10.7150/ijbs.64752↗
- RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2019.03.036↗
- Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma. First author DOI 10.1038/onc.2016.458↗
- Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2016.05.016↗
- Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ijms17060799↗
- SCF, regulated by HIF-1α, promotes pancreatic ductal adenocarcinoma cell progression. Co-author DOI 10.1371/journal.pone.0121338↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jihui Hao · 6 shared papers, 2015–2023 · strength 0.54
- Paper Retraction notice to "HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal… DOI 10.1016/j.canlet.2023.216059↗
- Paper SOX8 Affects Tumoral SPARC Expression by Regulating EZH2 to Attenuate Effectiveness of albumin-bound paclitaxel in PDAC. DOI 10.7150/ijbs.64752↗
- Paper RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarci… DOI 10.1016/j.canlet.2019.03.036↗
- Xiuchao Wang · 5 shared papers, 2015–2023 · strength 0.39
- Paper Retraction notice to "HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal… DOI 10.1016/j.canlet.2023.216059↗
- Paper RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarci… DOI 10.1016/j.canlet.2019.03.036↗
- Paper Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma. DOI 10.1038/onc.2016.458↗
- Tiansuo Zhao · 4 shared papers, 2015–2023 · strength 0.34
- Paper Retraction notice to "HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal… DOI 10.1016/j.canlet.2023.216059↗
- Paper RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarci… DOI 10.1016/j.canlet.2019.03.036↗
- Paper Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma. DOI 10.1038/onc.2016.458↗
- Shengyu Yang · 3 shared papers, 2016–2022 · strength 0.26
- Paper SOX8 Affects Tumoral SPARC Expression by Regulating EZH2 to Attenuate Effectiveness of albumin-bound paclitaxel in PDAC. DOI 10.7150/ijbs.64752↗
- Paper Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma. DOI 10.1038/onc.2016.458↗
- Paper Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2016.05.016↗
- Liangliang Wu · 2 shared papers, 2019–2023 · strength 0.24
- Paper Retraction notice to "HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal… DOI 10.1016/j.canlet.2023.216059↗
- Paper RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarci… DOI 10.1016/j.canlet.2019.03.036↗
- Haotian Wang · 2 shared papers, 2019–2023 · strength 0.24
- Paper Retraction notice to "HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal… DOI 10.1016/j.canlet.2023.216059↗
- Paper RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarci… DOI 10.1016/j.canlet.2019.03.036↗
- Chongbiao Huang · 3 shared papers, 2016–2017 · strength 0.17
- Paper Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma. DOI 10.1038/onc.2016.458↗
- Paper Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adeno… DOI 10.3390/ijms17060799↗
- Paper Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2016.05.016↗
- He Ren · 3 shared papers, 2015–2017 · strength 0.16
- Paper Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma. DOI 10.1038/onc.2016.458↗
- Paper Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adeno… DOI 10.3390/ijms17060799↗
- Paper SCF, regulated by HIF-1α, promotes pancreatic ductal adenocarcinoma cell progression. DOI 10.1371/journal.pone.0121338↗
- Yizhang Zhou · 1 shared paper, 2022 · strength 0.15
- Shuai Yuan · 1 shared paper, 2022 · strength 0.15
- Zhe Liu · 1 shared paper, 2022 · strength 0.15
- Song Gao · 1 shared paper, 2022 · strength 0.15
- Zengxun Li · 2 shared papers, 2016–2019 · strength 0.14
- Paper RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarci… DOI 10.1016/j.canlet.2019.03.036↗
- Paper Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adeno… DOI 10.3390/ijms17060799↗
- He Ren · 2 shared papers, 2016–2019 · strength 0.14
- Jie Dong · 2 shared papers, 2016–2017 · strength 0.11
- Yanhui Yang · 2 shared papers, 2016 · strength 0.11
- Na Li · 1 shared paper, 2016 · strength 0.05
- Yu Xu · 1 shared paper, 2016 · strength 0.05
- Wenna Jiang · 1 shared paper, 2016 · strength 0.05
- Ming Yu · 1 shared paper, 2016 · strength 0.05
- Chuntao Gao · 1 shared paper, 2015 · strength 0.04
- Jing Chen · 1 shared paper, 2015 · strength 0.04
- Xiao Ling Zhao · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.